Lb Pharmaceuticals (LBRX) Treasury Shares (2024 - 2025)

Lb Pharmaceuticals' Treasury Shares history runs 3 years deep, the most recent figure standing at $92000.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 68.86% year-over-year to $92000.0; the TTM figure through Mar 2026 stood at $92000.0 (down 68.86% YoY), while the FY2025 annual figure was $6.6 million, down 91.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $92000.0, down from $6.6 million in the prior quarter.
• The five-year high for Treasury Shares was $73.8 million in Q4 2024, with the low at $92000.0 in Q1 2026.
• The 3-year median for Treasury Shares is $3.7 million (2024), against an average of $16.9 million.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares sank 91.0% in 2025, then slumped 68.86% in 2026.
• Lb Pharmaceuticals' Treasury Shares stood at $73.8 million in 2024, then tumbled by 91.0% to $6.6 million in 2025, then tumbled by 98.62% to $92000.0 in 2026.
• Business Quant data shows LBRX's Treasury Shares at $92000.0 in Q1 2026, $6.6 million in Q4 2025, and $295467.0 in Q1 2025.